News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
774 Results
Type
Article (88)
Company Profile (2)
Press Release (684)
Section
Business (186)
Career Advice (4)
Deals (30)
Drug Delivery (3)
Drug Development (113)
FDA (10)
Job Trends (19)
News (338)
Policy (23)
Tag
2027 Biotech Bay Standard (1)
Academia (9)
Alliances (69)
ALS (1)
Alzheimer's disease (15)
Approvals (10)
Artificial intelligence (7)
Autoimmune disease (2)
Automation (2)
Best Places to Work (17)
Biotechnology (1)
Brain cancer (2)
Breast cancer (1)
Cancer (8)
Career advice (4)
CAR-T (5)
Cell therapy (11)
Clinical research (95)
Collaboration (13)
COVID-19 (1)
CRISPR (1)
C-suite (8)
Cystic fibrosis (1)
Data (16)
Diagnostics (2)
Drug discovery (3)
Earnings (41)
Events (96)
Executive appointments (2)
FDA (13)
Frontotemporal dementia (1)
Funding (4)
Gene editing (1)
Gene therapy (6)
Government (1)
Healthcare (12)
HIV (1)
Immunology and inflammation (1)
Indications (1)
Infectious disease (1)
Intellectual property (1)
Interviews (1)
IPO (10)
Job creations (4)
Job search strategy (4)
JPM (2)
Layoffs (1)
Legal (2)
Machine learning (1)
Manufacturing (12)
Medical device (9)
Medtech (10)
Mergers & acquisitions (17)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (22)
Neurotech (1)
NextGen: Class of 2026 (8)
Non-profit (5)
Opinion (2)
Patents (2)
Patient recruitment (1)
People (74)
Pharmaceutical (1)
Phase 1 (19)
Phase 2 (25)
Phase 3 (55)
Pipeline (17)
Policy (1)
Postmarket research (3)
Preclinical (18)
Prostate cancer (1)
Radiopharmaceuticals (1)
Rare diseases (2)
Real estate (12)
Regulatory (25)
Research institute (6)
RNA editing (1)
Startups (3)
Vaccines (2)
Venture capital (1)
Date
Last 7 days (1)
Last 30 days (11)
Last 365 days (80)
2026 (16)
2025 (69)
2024 (63)
2023 (52)
2022 (63)
2021 (47)
2020 (33)
2019 (64)
2018 (48)
2017 (35)
2016 (34)
2015 (36)
2014 (21)
2013 (34)
2012 (24)
2011 (30)
2010 (26)
Location
Asia (27)
Australia (4)
California (22)
Canada (5)
China (3)
Europe (164)
Florida (1)
Japan (3)
Maryland (39)
Massachusetts (8)
New Jersey (2)
New York (1)
Northern California (19)
Pennsylvania (4)
Southern California (3)
United States (78)
Washington State (3)
Wisconsin (1)
774 Results for "shuttle pharmaceuticals.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Shuttle Executes LOI with Molecule.ai
October 13, 2025
·
4 min read
Press Releases
Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH)
October 23, 2025
·
7 min read
Press Releases
Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH)
October 21, 2025
·
8 min read
Press Releases
Shuttle Pharma Provides Second Quarter 2025 Corporate Update
August 15, 2025
·
5 min read
Press Releases
Manifold Bio Announces Strategic Collaboration with Roche to Develop Multiple Next-Generation Brain Shuttles for Neurological Diseases
November 4, 2025
·
5 min read
Press Releases
Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH)
October 23, 2025
·
7 min read
Press Releases
Shuttle Pharma Provides Corporate Update
May 15, 2025
·
5 min read
Alzheimer’s disease
Novartis Makes $1.5B+ Alzheimer’s Play With China’s SciNeuro
The deal will see Novartis gain global rights over SciNeuro’s potentially disease-modifying anti-amyloid antibody, which leverages the latter’s proprietary shuttle platform to allow delivery into the brain.
January 12, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors
June 5, 2025
·
3 min read
Neuroscience
Roche Piles $55M Into Blood-Brain Barrier Tech With Manifold
Manifold will use its tissue-targeting shuttle technology to help Roche develop new therapeutics for diseases of the central nervous system.
November 3, 2025
·
1 min read
·
Annalee Armstrong
1 of 78
Next
